Crown (NYSE:CCK) Price Target Raised to $130.00

Crown (NYSE:CCKGet Free Report) had its target price increased by equities researchers at Mizuho from $120.00 to $130.00 in a research note issued to investors on Thursday,Benzinga reports. The brokerage currently has an “outperform” rating on the industrial products company’s stock. Mizuho’s price objective indicates a potential upside of 12.81% from the company’s previous close.

Other analysts have also issued research reports about the company. UBS Group boosted their price target on Crown from $125.00 to $126.00 and gave the company a “buy” rating in a report on Monday, January 12th. Truist Financial lifted their price objective on Crown from $126.00 to $130.00 and gave the company a “buy” rating in a report on Tuesday, January 6th. Wall Street Zen upgraded shares of Crown from a “hold” rating to a “buy” rating in a report on Sunday, January 18th. Royal Bank Of Canada boosted their price target on shares of Crown from $116.00 to $120.00 and gave the company an “outperform” rating in a report on Wednesday, October 22nd. Finally, Raymond James Financial reaffirmed an “outperform” rating and issued a $115.00 price target (up previously from $110.00) on shares of Crown in a research report on Wednesday, October 22nd. Twelve investment analysts have rated the stock with a Buy rating and two have issued a Hold rating to the company’s stock. According to MarketBeat.com, Crown presently has an average rating of “Moderate Buy” and a consensus target price of $120.38.

View Our Latest Research Report on Crown

Crown Stock Performance

Crown stock opened at $115.24 on Thursday. The firm has a market capitalization of $13.29 billion, a P/E ratio of 14.26, a price-to-earnings-growth ratio of 1.29 and a beta of 0.73. The company’s 50-day moving average is $102.40 and its 200 day moving average is $99.19. Crown has a 1-year low of $75.98 and a 1-year high of $115.72. The company has a debt-to-equity ratio of 1.65, a current ratio of 1.16 and a quick ratio of 0.76.

Crown (NYSE:CCKGet Free Report) last issued its quarterly earnings results on Wednesday, February 4th. The industrial products company reported $1.74 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.69 by $0.05. Crown had a return on equity of 26.86% and a net margin of 7.79%.The firm had revenue of $3.13 billion during the quarter, compared to analyst estimates of $2.99 billion. During the same period last year, the company earned $1.59 EPS. Crown’s quarterly revenue was up 7.7% compared to the same quarter last year. Crown has set its FY 2026 guidance at 7.900-8.300 EPS and its Q1 2026 guidance at 1.700-1.800 EPS. Research analysts forecast that Crown will post 6.96 EPS for the current year.

Insider Activity

In other Crown news, COO Djalma Novaes, Jr. sold 19,754 shares of the company’s stock in a transaction that occurred on Tuesday, December 16th. The shares were sold at an average price of $101.02, for a total transaction of $1,995,549.08. Following the transaction, the chief operating officer owned 96,841 shares in the company, valued at approximately $9,782,877.82. This represents a 16.94% decrease in their position. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CEO Timothy J. Donahue sold 29,024 shares of the firm’s stock in a transaction on Monday, January 5th. The stock was sold at an average price of $105.00, for a total transaction of $3,047,520.00. Following the completion of the transaction, the chief executive officer directly owned 411,556 shares of the company’s stock, valued at approximately $43,213,380. This represents a 6.59% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. In the last 90 days, insiders have sold 64,754 shares of company stock worth $6,720,634. Corporate insiders own 0.90% of the company’s stock.

Hedge Funds Weigh In On Crown

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. ORG Partners LLC grew its stake in Crown by 52.5% during the 4th quarter. ORG Partners LLC now owns 305 shares of the industrial products company’s stock valued at $31,000 after purchasing an additional 105 shares during the last quarter. Geneos Wealth Management Inc. boosted its position in Crown by 45.3% in the first quarter. Geneos Wealth Management Inc. now owns 356 shares of the industrial products company’s stock valued at $32,000 after buying an additional 111 shares during the last quarter. ProShare Advisors LLC boosted its position in Crown by 2.3% in the second quarter. ProShare Advisors LLC now owns 5,101 shares of the industrial products company’s stock valued at $525,000 after buying an additional 113 shares during the last quarter. DekaBank Deutsche Girozentrale increased its holdings in Crown by 1.2% in the 2nd quarter. DekaBank Deutsche Girozentrale now owns 9,477 shares of the industrial products company’s stock worth $983,000 after buying an additional 114 shares during the period. Finally, Siemens Fonds Invest GmbH raised its position in Crown by 7.7% during the 3rd quarter. Siemens Fonds Invest GmbH now owns 1,626 shares of the industrial products company’s stock worth $157,000 after buying an additional 116 shares during the last quarter. Hedge funds and other institutional investors own 90.93% of the company’s stock.

Trending Headlines about Crown

Here are the key news stories impacting Crown this week:

About Crown

(Get Free Report)

Crown Holdings, Inc is a leading global supplier of rigid packaging products for consumer goods markets. The company designs, manufactures and sells metal packaging for beverage, food, household, personal care and specialty products. Its portfolio includes aluminum and steel beverage cans, steel food cans, aluminum aerosols, metal closures and ends, offering customers end-to-end solutions from design and prototyping to large-scale production.

Founded in 1919 as the Crown Cork & Seal Company, Crown has grown through strategic acquisitions and investments in advanced manufacturing technologies.

Featured Articles

Analyst Recommendations for Crown (NYSE:CCK)

Receive News & Ratings for Crown Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Crown and related companies with MarketBeat.com's FREE daily email newsletter.